KVARTALSRAPPORT JANUARI-SEPTEMBER 2023

MAR

THIRD QUARTER, JULY-SEPTEMBER 2023

  • Net sales amounted to MSEK 0.0 (0.0)
  • Operating loss (EBIT) amounted to MSEK -5.6 (-4.5)
  • Net loss amounted to MSEK -5.5 (-4.5)
  • Net cash flow amounted to MSEK -4.6 (-7.4)
  • EPS before and after dilution amounted to SEK -0.06 (-0.17)

 
JANUARY- SEPTEMBER 2023

  • Net sales amounted to MSEK 0.0 (0.0)
  • Operating loss (EBIT) amounted to MSEK -17.8 (-20.5)
  • Net loss amounted to MSEK -18.3 (-20.5)
  • Net cash flow amounted to MSEK 7.7 (-9.1)
  • EPS before and after dilution amounted to SEK -0.32 (-0.87)

 
Significant events
During the reporting period

  • In August, Emplicure hired Johan Magné as Sales Director with a long background in Swedish Match to drive the company's sales of smååTM.
  • In September, the company received a research grant of MSEK 1.0 from Vinnova, Sweden's Innovation Authority, within the framework of the competence center SweDeliver.
  • Also in September, the company announced that the company, through its subsidiary Amplicon, initiates a collaboration on a clinical study with CTC Clinical Trial Consultants AB, a recognized contract research organization (CRO).

 
After the reporting period

  • In October the company was informed that a buyout consortium had agreed to acquire over 90 per cent of the shares in Emplicure and intends to initiate squeeze-out proceedings.
  • In November Emplicure announced the hiring of a marketing manager, Sophia Bailey
  • In November the buyout consortium initiated squeeze-out proceedings and Emplicure applied for delisting. Nasdaq approved the delisting with the 27 November as the last trading day
Datum 2023-11-17, kl 07:58
Källa MFN
Bifogade filer
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet